Nuzenio

Net Product Revenue

Net Product Revenue news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 7 publisher sources 100/100 entity strength

Latest news

BridgeBio Pharma 2026: Revenue $243.68M, EPS ($0.78) — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 20:35:17 GMTBridgeBio Pharma posts Q2 revenue $243.7M led by $222.4M Attruby product sales; net loss $152.2M - TradingViewTradingView · Mon, 10 Aug 2026 20:14:34 GMTTonix Pharmaceuticals posts $13.5M Q2 product revenue, $40.6M net loss - TradingViewTradingView · Mon, 10 Aug 2026 11:23:01 GMTAxsome Q2 Revenue Rises 46 Percent To $218.4 Million - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 11:12:00 GMTAxsome Reports 126% More AUVELITY Starts Among 65+ Patients in 8 Weeks - Stock TitanStock Titan · Mon, 10 Aug 2026 11:06:21 GMTTonix's Fibromyalgia Treatment Reaches 136M Covered Lives - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMTDenali Q2 2026 earnings: AVLAYAH debuts with $3.6 million in revenue - TradingKeyTradingKey · Thu, 06 Aug 2026 22:06:36 GMTX4 Pharmaceuticals Q2 2026 Earnings: License Revenue Helps Narrow the Net Loss - TradingKeyTradingKey · Thu, 06 Aug 2026 21:08:19 GMT

Timeline

Mon, 10 Aug 2026 20:35:17 GMTBridgeBio Pharma 2026: Revenue $243.68M, EPS ($0.78) — 10-Q Summary - TradingView
Mon, 10 Aug 2026 20:14:34 GMTBridgeBio Pharma posts Q2 revenue $243.7M led by $222.4M Attruby product sales; net loss $152.2M - TradingView
Mon, 10 Aug 2026 11:23:01 GMTTonix Pharmaceuticals posts $13.5M Q2 product revenue, $40.6M net loss - TradingView
Mon, 10 Aug 2026 11:12:00 GMTAxsome Q2 Revenue Rises 46 Percent To $218.4 Million - Quiver Quantitative
Mon, 10 Aug 2026 11:06:21 GMTAxsome Reports 126% More AUVELITY Starts Among 65+ Patients in 8 Weeks - Stock Titan
Mon, 10 Aug 2026 11:00:00 GMTTonix's Fibromyalgia Treatment Reaches 136M Covered Lives - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Net Product Revenue.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.